Sabby Management, LLC Phio Pharmaceuticals Corp. Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.99 - $1.99 $40,277 - $80,961	-40,684 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.62 - $2.28 $17,936 - $25,244	-11,072 Reduced 21.39%	40,684 $83,000
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.8 $53,760 - $80,497	28,749 Added 124.96%	51,756 $117,000
Q1 2021 May 17, 2021	BUY	$2.48 - $4.05 $57,057 - $93,178	23,007 New	23,007 $62,000
Q2 2020 Aug 14, 2020	SELL	$1.68 - $3.05 $428,725 - $778,341	-255,194 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.77 - $12.93 $451,693 - $3.3 Million	255,194 New	255,194 $452,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $47.8M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.